Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Keryx Biopharmaceuticals aggregated by PharmaCompass.com.

    Client Virtual Booth

    KERYX BIOPHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Keryx Biopharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Keryx Biopharmaceuticals, Inc. One Marina Park Drive, 12th Floor Boston, MA 02210
    Telephone
    Telephone
    +1(617)-466-3500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://keryx.com
    Linkedin
    Linkedin
    https://www.linkedin.com/company/keryx-biopharmaceuticals/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Enforcement Report - Week of February 24, 2021
    Enforcement Report - Week of February 24, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-24-2021-1614247020.pdf

    FDA
    24 Feb 2021
    Share Share
    Enforcement Report - Week of December 30, 2020
    Enforcement Report - Week of December 30, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-30-2020-1609403374.pdf

    FDA
    30 Dec 2020
    Share Share
    Enforcement Report - Week of July 22, 2020
    Enforcement Report - Week of July 22, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-22-2020-1595395565.pdf

    FDA
    22 Jul 2020
    Share Share
    Auryxia (Ferric Citrate) : Keryx Biopharma vs. Mylan Pharma
    Auryxia (Ferric Citrate) : Keryx Biopharma vs. Mylan Pharma

    https://insight.rpxcorp.com/litigation_documents/13273546

    PATENT LITIGATION
    18 Mar 2019
    Share Share
    Auryxia (Ferric Citrate) : Keryx Biopharmaceuticals vs. Teva Pharmaceuticals
    Auryxia (Ferric Citrate) : Keryx Biopharmaceuticals vs. Teva Pharmaceuticals

    https://insight.rpxcorp.com/litigation_documents/13179787

    PATENT LITIGATION
    20 Dec 2018
    Share Share
    Akebia Therapeutics, Keryx Biopharms Announce Chairperson for Combined Company
    Akebia Therapeutics, Keryx Biopharms Announce Chairperson for Combined Company

    https://www.businesswire.com/news/home/20181115006066/en/Akebia-Therapeutics-Keryx-Biopharmaceuticals-Announce-Chairperson-Combined

    BUSINESSWIRE
    16 Nov 2018
    Share Share
    Wolf Popper Investigates the Proposed Acq of Keryx Biopharmaceuticals by Akebia
    Wolf Popper Investigates the Proposed Acq of Keryx Biopharmaceuticals by Akebia

    https://www.prnewswire.com/news-releases/wolf-popper-llp-investigates-the-proposed-acquisition-of-keryx-biopharmaceuticals-inc-by-akebia-therapeutics-inc-300684969.html

    PR NEWSWIRE
    23 Jul 2018
    Share Share
    Akebia Therapeutics and Keryx Biopharmaceuticals merge, creating a $1bn company
    Akebia Therapeutics and Keryx Biopharmaceuticals merge, creating a $1bn company

    https://www.healthcareglobal.com/public-health/akebia-therapeutics-and-keryx-biopharmaceuticals-merge-creating-1bn-company

    C. STURMAN HEALTHCARE GLOBAL
    02 Jul 2018
    Share Share
    Bragar Eagel & Squire, is Investigating the Board of Directors of Keryx
    Bragar Eagel & Squire, is Investigating the Board of Directors of Keryx

    https://globenewswire.com/news-release/2018/07/02/1532524/0/en/Bragar-Eagel-Squire-P-C-is-Investigating-the-Board-of-Directors-of-Keryx-Biopharmaceuticals-Inc-NASDAQ-KERX-on-Behalf-of-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html

    GLOBENEWSWIRE
    02 Jul 2018
    Share Share
    Akebia, Keryx to merge, creating kidney disease specialist
    Akebia, Keryx to merge, creating kidney disease specialist

    https://www.fiercebiotech.com/akebia-keryx-to-merge-creating-kidney-disease-specialist-ahead-showdown-fibrogen-glaxosmithkline

    Nick P. Taylor FIERCE BIOTECH
    29 Jun 2018
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search